Prof. Uwe Siebert, MD, MPH, MSc, ScD, Professor of Public Health, is the Chair of the Department of Public Health, Information Systems and Health Technology Assessment at UMIT - University of Health Sciences, Medical Informatics and Technology in Austria. He is also Adjunct Professor of Health Policy and Management at the Harvard School of Public Health and Associate Professor of Radiology at Harvard Medical School, where he directs the Program on Cardiovascular Research at the Institute for Technology Assessment, Massachusetts General Hospital, Boston. He has an adjunct teaching appointment at the School of Public Health and Epidemiology at the University of Munich.
After medical school, Prof. Siebert worked for several years as a physician in international public health projects. He then earned an MPH at the Munich School of Public Health, and completed an MSc in Epidemiology and an ScD in Health Policy and Management with a concentration in decision sciences at the Harvard School of Public Health. Before he started his faculty position at Harvard Medical School, he was the Director of the Bavarian Public Health Research and Coordinating Center at the University of Munich, Germany, and completed Visiting Scholarship at the Harvard Center for Risk Analysis.
His research interests include applying decision-analytic modeling, meta-analysis, quality-of-life assessment and cost-effectiveness analysis in the framework of health technology assessments (HTA) as well as in the clinical context of routine health care. His current substantive research focuses on cancer, cardiovascular disease, diabetes, hepatitis C, HIV, and neurological disorders. His methodological research is focused on evaluations of public health interventions, prevention and screening, diagnostic imaging procedures, personalized medicine, information systems as well as the development of causal decision models based on complex longitudinal data with time-varying interventions or exposures.
Prof. Siebert is a member of the Board of Trustees of the Society of Medical Decision Making (SMDM), a member of the International Expert Committee Advising the Institute for Quality and Efficiency in Health Care (IQWiG) on the Methods for Economic Evaluations of Health Care Interventions, a member of the Latin America Consortium Advisory Committee of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), a member of the Advisory Board of the Ludwig Boltzmann Institute for Health Technology Assessment in Austria, a member of the ‘National HTA Strategy' Expert Group of the Austrian Ministry of Health, a member of the Working Group "Methods of the Assessment of Cost-Benefit Relations" of the Scientific Advisory Board of IQWIG, and he has served as a member of the Board of Directors of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR). He is member of the Steering Committee of ONCOTYROL - Center of Personalized Cancer Medicine in Austria and Director of the Division for Public Health Decision Modeling, HTA and Health Economics in the Center. He is the Chairman of the Working Groups "Health Economics" and "Medical Decision Making" of the German Society for Medical Informatics, Biometry and Epidemiology (GMDS). He is Co-Chair of the "Issues in Methodology Section" of the SMDM Policy Initiative and a Leadership Member of the ISPOR Personalized Medicine Special Interest Group. He teaches courses in decision analysis, HTA, economic evaluation, and advanced epidemiologic methods at several universities and for industry in Europe, USA, and South America. He advises government agencies, academic institutions and the industry regarding the conduction and impact of health technology assessments on policy and reimbursement decisions. He has authored more than 200 publications including HTA reports, textbook chapters, scientific articles, and editorials.
